GLOBAL MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Jan 2019 152

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.

Scope of the Report:
This report studies the Musculoskeletal Disorders Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Musculoskeletal Disorders Therapeutics market by product type and applications/end industries.
MSDs mostly occur because of the over-exhaustion of weak muscles, ligaments, or tendons. Also, vigorous vocational activities can lead to musculoskeletal pain. Uncured MSDs can result in chronic disruption of the mundane and vocational tasks of the patient. Some of the major therapeutics to treat MSDs include corticosteroids, biologics, parathyroid hormone, selective estrogen receptor modulators, protein therapy, synthetic bone graft, demineralized bone matrix, composite grafts, and BMPS, orthobiologics.
The global Musculoskeletal Disorders Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Musculoskeletal Disorders Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
- Pfizer
- AbbVie
- Johnson & Johnson
- Sanofi
- Merck
- Novartis
- Eli Lilly
- AstraZeneca
- Boehringer Ingelheim
- F. Hoffmann-La Roche
- Amgen
- Takeda Pharmaceutical
- Daiichi Sankyo
- LG Life Sciences
- Astellas
- Samsung Bioepis
- Zosano Pharma
- Taisho Pharmaceutical
- 3SBio

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Biologics
- Small Molecules
- Other

Market Segment by Applications, can be divided into
- Osteoarthritis
- Osteoporosis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Fibromyalgia
- Other

Table of Contents

Related reports :

(Mar 19)

Silver dressings are a relatively new family of advanced wound care dressings for the treatment of infected wounds. A silver dressing is a w...

(Mar 19)

This report studies the Neuropathy Pain Treatment market, Neuropathic pain is pain caused by damage or disease affecting the somatose...

(Mar 19)

Hyaluronic Acid Dermal Filler are the product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, an...

(Mar 19)

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properti...

(Mar 19)

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of t...

(Mar 19)

Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic...

GLOBAL MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy